" class="no-js "lang="en-US"> Bayer Archives - Medtech Alert
Saturday, March 25, 2023

Sort by:


Top Post

Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer

Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]

Bayer’s Bluerock Therapeutics Establishes European Site for Cell Therapy Innovation

Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and […]

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the […]

Bayer Announces Changes in Executive Leadership Team of Crop Science Division

Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]

Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing

Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]

Bayer Announces Christoph Koenen as New Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer

Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations […]

Bayer to Invest Over €400 Million to Increase Access to Modern Contraception

Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]

Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients

Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the […]

Ada Health Secures £63m Investment to Enhance Assessment Tech

Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The […]

Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health

Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has […]

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more